Insider Trading History of Armitage James O

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Armitage James O since 2014. This trader's CIK number is 1370087. At the time of last reporting, Armitage James O was the Officer of Cardiff Oncology, Inc.. (stock ticker symbol CRDF). Also see all insider trading activities at Cardiff Oncology, Inc..

Note that in the past Armitage James O also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Cardiff Oncology, Inc. (CRDF) by Armitage James O

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 CRDF 13,000 $20,228 0 $0 0 $0
2021 CRDF 4,000 $43,272 0 $0 0 $0
2020 CRDF 10,490 $15,000 0 $0 0 $0

Yearly summary of insider trading at Tesaro, Inc. (TSRO) by Armitage James O

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 TSRO 0 $0 10,000 $1,170,500 10,000 $263,600
2015 TSRO 500 $27,316 0 $0 0 $0
2014 TSRO 1,000 $38,155 0 $0 0 $0


Insider trading activities at 2 companies by Armitage James O:

1. Cardiff Oncology, Inc. (CRDF)

2. Tesaro, Inc. (TSRO)

Table 1. Insider trading of Cardiff Oncology, Inc. (CRDF) by Armitage James O

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-09-16 CRDF Buy 13,000 1.56 20,228
2021-03-19 CRDF Buy 4,000 10.82 43,272
2020-05-14 CRDF Buy 10,490 1.43 15,000

Table 2. Insider trading of Tesaro, Inc. (TSRO) by Armitage James O

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-09-18 TSRO Sale 10,000 117.05 1,170,500
2017-09-18 TSRO Option Ex 10,000 26.36 263,600
2015-09-08 TSRO Buy 500 54.63 27,316
2014-12-12 TSRO Buy 1,000 38.16 38,155

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Armitage James O (Officer of Cardiff Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.